Table 2B.
Fold Increasea | Avg Fold Increased | |||||||
---|---|---|---|---|---|---|---|---|
Gene | Exp 1b | Exp 2c | Exp 3c | SEMe | Name | Functionf | HSV | |
ORF38 | 1.54 | 1.45 | 1.76 | 1.60 | 0.155 | UL38 | Thymidine kinase | UL23 |
IR3 | 1.52 | 1.17 | 2.03 | 1.60 | 0.430 | IR3 | microRNA | none |
ORF39 | 1.67 | 1.41 | 1.78 | 1.60 | 0.185 | UL39 | gH | UL22 |
ORF18 | 1.89 | 1.54 | 1.61 | 1.58 | 0.035 | UL18 | DNA process | UL42 |
ORF45 | 1.59 | 1.42 | 1.73 | 1.57 | 0.155 | UL45 | Tegument req. for cleavage/packaging | UL17 |
ORF74 | 1.33 | 1.45 | 1.59 | 1.52 | 0.070 | US7 | gE | US8 |
ORF17 | 1.10 | 1.61 | 1.43 | 1.52 | 0.090 | UL17 | Membrane | UL43 |
ORF46 | 1.93 | 1.38 | 1.63 | 1.50 | 0.125 | UL46 | Capsid-assoc. req. for cleavage/packaging | UL16 |
ORF49 | 1.77 | 1.35 | 1.66 | 1.50 | 0.155 | UL49 | Tyr protein kinase | UL13 |
ORF75 | 1.96 | 1.40 | 1.60 | 1.50 | 0.100 | US8 | “10K” | none |
ORF34 | 1.96 | 1.45 | 1.54 | 1.49 | 0.045 | UL34 | ?? | none |
ORF29 | 1.61 | 1.37 | 1.61 | 1.49 | 0.120 | UL29 | Req. for envelopment | UL31 |
ORF50 | 1.69 | 1.38 | 1.59 | 1.49 | 0.105 | UL50 | Alkaline Dnase | UL12 |
ORF28 | 1.56 | 1.35 | 1.59 | 1.47 | 0.120 | UL28 | Cleavage/packaging | UL32 |
ORF8 | 1.34 | 1.32 | 1.61 | 1.47 | 0.145 | UL8 | Tegument | UL51 |
ORF27 | 1.29 | 1.27 | 1.64 | 1.46 | 0.185 | UL27 | Packaging | UL33 |
ORF24 | 1.53 | 1.37 | 1.54 | 1.46 | 0.085 | UL24 | ICP1/2 tegument | UL36 |
ORF69 | 1.23 | 1.44 | 1.45 | 1.45 | 0.005 | US2 | Protein kinase | US3 |
ORF25 | 2.18 | 1.27 | 1.61 | 1.44 | 0.170 | UL25 | Capsid | UL35 |
ORF20 | 1.93 | 1.24 | 1.64 | 1.44 | 0.200 | UL20 | RR2 | UL40 |
ORF7 | 1.19 | 1.27 | 1.56 | 1.42 | 0.145 | UL7 | Helicase/primase | UL52 |
ORF26 | 1.66 | 1.30 | 1.52 | 1.41 | 0.110 | UL26 | Membrane | UL34 |
ORF5 | 1.32 | 1.31 | 1.46 | 1.39 | 0.075 | UL5 | EICP27 | UL54 |
ORF51 | 2.13 | 1.21 | 1.56 | 1.38 | 0.175 | UL51 | Virion and envelopment | UL11 |
ORF31 | 1.57 | 1.36 | 1.40 | 1.38 | 0.020 | UL31 | ICP8 ssDNA-binding protein | UL29 |
ORF48 | 1.22 | 1.17 | 1.58 | 1.38 | 0.205 | UL48 | Tegument | UL14 |
ORF21 | 1.31 | 1.24 | 1.47 | 1.36 | 0.115 | UL21 | RR1 | UL39 |
ORF67 | 1.91 | 1.35 | 1.36 | 1.36 | 0.005 | IR6 | Virion forms filaments | none |
IR4/UL3 | 1.31 | 1.18 | 1.45 | 1.32 | 0.135 | Hybrid | none | |
ORF32 | 1.09 | 1.19 | 1.30 | 1.24 | 0.055 | UL32 | Cleavage/packaging | UL28 |
ORF64.1 | 0.74 | 0.95 | 1.50 | 1.23 | 0.275 | IR1 | IE | ICP4 |
ORF76 | 0.94 | 1.14 | 1.29 | 1.22 | 0.075 | US9 | Tegument | US9 |
ORF63 | 1.35 | 1.00 | 1.36 | 1.18 | 0.180 | UL63 | EICP0 | IE110 |
ORF65 | 1.13 | 1.00 | 1.25 | 1.13 | 0.125 | IR4 | EICP22 | US1 |
ORF1g | −1.06 | 0.69 | 1.50 | 1.10 | 0.405 | UL1 | MHC-I downregulation, immune evasion | UL56 |
Actin | 0.80 | 1.01 | 1.00 | 1.00 | 0.005 | |||
GAPDH | 1.00 | 1.00 | 1.00 | 1.00 | 0.000 | |||
ORF4h | −0.10 | 0.17 | 0.38 | 0.27 | 0.105 | UL4 | Inhibitory protein req. for DIP generation | UL55 |
Fold increase ΔUL4 EHV-1 vs. wild-type EHV-1. Data are from three independent experiments (Exp)
Infection MOI 5
Infection MOI 10
Average fold increase for Exps 2 & 3
Standard error from mean Exps 2 & 3
Function or location is assigned based on sequence analysis (Telford et al., 1992)
ORF1 deleted in both wild-type EHV-1 and ΔUL4 EHV-1
ORF4 deleted in ΔUL4 EHV-1 but present in wild-type EHV-1